Scilex Holding (SCLXW)
0.20
-0.01 (-4.76%)
At close: Jan 30, 2025, 2:58 PM
0.24
22.05%
After-hours Jan 30, 2025, 04:58 PM EST
undefined% (undefined)
| Bid | 0.12 |
| Market Cap | 111.92M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.27 |
| Volume | 1,000 |
| Avg. Volume (20D) | 0 |
| Open | 0.20 |
| Previous Close | 0.21 |
| Day's Range | 0.20 - 0.20 |
| 52-Week Range | 0.20 - 0.20 |
| Beta | undefined |
About SCLXW
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company's principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid f...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date n/a
Employees 113
Stock Exchange NASDAQ
Ticker Symbol SCLXW
Website https://www.scilexholding.com